Clinical Trial Update: HiFIT Study : Hip Fracture: Iron and Tranexamic Acid [Phase 3]

View source ↗

Summary

Phase 3 trial update for HiFIT study evaluating iron and tranexamic acid in hip fracture with pathologic fracture and anemia; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fractures

Drugs mentioned

• Iron (ferrous iron)
• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University Hospital, Angers | Conditions: Hip Fractures Pathologic, Anemia | Phase 3 | Status: TERMINATED